Prescribed List Reforms - Consultation Paper 10 - General Use Items utilisation, expenditure and integrity
Overview
On 1 May 2024, the Minister of Health and Aged Care announced that general use items (GUI) would be retained on Part D of the Prescribed List (PL). This decision follows consistent feedback from multiple stakeholders that removing the GUIs from the PL without an alternative funding arrangement would have negative clinical implications and potential adverse outcomes for patients.
Some stakeholders raised concerns about the increasing growth in use per episode of care and the resulting expenditure for these products, following the announcement to retain GUIs on the PL. The department is undertaking further consultation and engagement to identify ways in which these concerns might be addressed – both regulatory and non-regulatory.
Why your views matter
We acknowledge that any measures implemented could have impacts for different stakeholder groups, and therefore we are interested in understanding all perspectives on this matter. We invite all stakeholders to complete our survey, or submit a written response.
In drafting your response, please provide as much detail and evidence as possible about the impacts as well as any options for consideration.
Give us your views
Audiences
- Non-government organisations
- State government agencies
- Commonwealth agencies
- Local governments
- Health professionals
- Health workforce
- Health staff
- HPRG (TGA) Staff
- Prescription medicines
- Complementary medicines
- Medical Devices & IVDs
Interests
- Hospitals
- Health technology
- Medicare
- Legislation
- Pharmaceutical benefits
- Health insurance
- Strategic Policy
- Policy Development
Share
Share on Twitter Share on Facebook